Concepedia

Jesús Corría-Osorio

JC

6

Publications

346

Citations

6

H-Index

2019

Active since

Affiliations

Ludwig Cancer Research(Current)

University of Lausanne

Swiss Cancer Center Léman

National and Kapodistrian University of Athens

University of Geneva

Jesús Corría-Osorio is an author at Ludwig Cancer Research specializing in tumor biology, medicine, and tumor immunity.

ORCID

Top concepts

Publications per year

2019–2025

6

Publications

6

PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function

Matteo Morotti, Alizée J Grimm, Helen Carrasco Hope et al. · Nature · 2024 · 163 citations · Full text

Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 <sup>+</sup> T-myeloid cell networks in melanoma

David Barras, Eleonora Ghisoni, Johanna Chiffelle et al. · Science Immunology · 2024 · 71 citations · Full text

Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells

Jesús Corría-Osorio, Santiago J. Carmona, Evangelos Stefanidis et al. · Nature Immunology · 2023 · 44 citations · Full text

Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma

Johanna Chiffelle, David Barras, Rémy Pétremand et al. · Immunity · 2024 · 36 citations

, , +11

Modulation of CD4 T cell function via CD6-targeting

Raquel Filipa Reis de Freitas, Afonso P. Basto, S. C. P. Almeida et al. · EBioMedicine · 2019 · 16 citations · Full text

Rows per page

1–5 of 6